Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collagenase in the Treatment of Cellulite
NCT00261144Phase 2Unknown
- Sponsor
- Stony Brook University
- Start
- Feb 2013
- Primary completion
- Feb 2014
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of collagenase clostridium histolyticum in cellulite, sponsored by Stony Brook University. Primary endpoint: Reduction and/or elimination of cellulite in the posterolateral thigh at 6 months. Status: unknown.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
cellulite
Beyond the preview
Go deeper on NCT00261144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261144.